EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights

Ângela Alves, Rui Medeiros, Ana Luísa Teixeira, Francisca Dias

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024

DOI: 10.1016/j.bbcan.2024.189165 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024. Verfasst von Ângela Alves und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology and Viral Pathology Group, Research Center of IPO-Porto (CI-IPOP) &RISE@CI-IPOP (Health Research Network), Portuguese Oncology Ins…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, PTEN Phosphohydrolase, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma is the most common adult renal solid tumor and the deadliest urological cancer, with clear cell renal cell carcinoma (ccRCC) being the predominant subtype. The PI3K/AKT signaling pathway assumes a central role in ccRCC tumorigenesis, wherein its abnormal activation confers a highly aggressive phenotype, leading to swift resistance against current therapies and distant metastasis. Thus, treatment resistance and disease progression remain a persistent clinical challenge in managing ccRCC effectively. PTEN, an antagonist of the PI3K/AKT signaling axis, emerges as a crucial factor in tumor progression, often experiencing loss or inactivation in ccRCC, thereby contributing to elevated mortality rates in patients. Therefore, understanding the molecular mechanisms underlying PTEN suppression in ccRCC tumors holds promise for the discovery of biomarkers and therapeutic targets, ultimately enhancing patient monitoring and treatment outcomes. The present review aims to summarize these mechanisms, emphasizing their potential prognostic, predictive, and therapeutic value in managing ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellPTEN PhosphohydrolaseKidney NeoplasmsBiomarkers, TumorSignal TransductionHumansProto-Oncogene Proteins c-aktGene Expression Regulation, NeoplasticPhosphatidylinositol 3-KinasesPrognosisAnimals

Stichwörter der Autor:innen

BiomarkersClear cell renal cell carcinomaPTENTherapeutic targets

Substanzen

PTEN PhosphohydrolasePTEN protein, humanBiomarkers, TumorProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Molecular Oncology and Viral Pathology Group, Research Center of IPO-Porto (CI-IPOP) &RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto), Porto Comprehensive Cancer Center (Porto.…

Förderung

  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Alves, Â., Medeiros, R., Teixeira, A. L., & Dias, F. (2024). Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2024.189165

Vancouver

Alves Â, Medeiros R, Teixeira AL, Dias F. Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024. doi:10.1016/j.bbcan.2024.189165

BibTeX
@article{Alves2024,
  author = {Alves, Ângela and Medeiros, Rui and Teixeira, Ana Luísa and Dias, Francisca},
  title = {Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2024},
  doi = {10.1016/j.bbcan.2024.189165}
}
Kostenlos starten →